Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer

Nutrition

Volumn 16, Issue 11-12, 2000, Pages 1084-1089

  Niles, Richard M ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cancer; Retinoids; Vitamin A metabolites

Indexed keywords

ALITRETINOIN; ALPHA INTERFERON; BETA CAROTENE; ISOTRETINOIN; N 4 (ETHOXYCARBOPHENYL)RETINAMIDE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOID X RECEPTOR; RETINOL; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CARCINOMA; CANCER INHIBITION; CANCER PREVENTION; CELL DIFFERENTIATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HEAD AND NECK CARCINOMA; HUMAN; LUNG CANCER; MITOSIS INHIBITION; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; SECOND CANCER; SKIN CARCINOMA; SOLID TUMOR; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA IN SITU; XERODERMA PIGMENTOSUM;

ANTICARCINOGENIC AGENTS; HUMANS; NEOPLASMS; RETINOIDS;

EID: 0033676093     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00436-6     Document Type: Review

References (113)

1. A decade of molecular biology of retinoic acid receptors
2. Control of retinoid nuclear receptor function and expression
3. Retinoids and mammalian development
4. Retinoids in development
5. Vitamin A functions in the productive organs
6. Retinoids and their receptors in differentiation, embryogenesis and neoplasia
7. The molecular basis of visual excitation
8. Vitamin A and reproduction in rats
9. The retinoid signaling pathway: Molecular and genetic analysis
10. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)
11. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells
12. The role of vitamins A, E and C in cancer cell biology
13. Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice
14. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma in vitro
15. Retinoic acid increases cyclic AMP-dependent protein kinase activity in murine melanoma cells
16. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
17. Identification of a receptor for the morphogen retinoic acid
18. A human retinoic acid receptor which belongs to the family of nuclear receptors
19. Roles of cellular retinol-binding protein and cellular retinoic acid-binding protein in the metabolic channeling of retinoids
20. Transfer of retinoic acid from its complex with cellular retinoic acid-binding protein to the nucleus
21. Nuclear detection of cellular retinoic acid binding proteins I and II with new antibodies
22. Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse and rat genomes
23. A functional retinoic acid receptor encoded by a gene on human chromosome 12
24. Mapping of the Rxr loci encoding nuclear retinoid X receptors RXRα, RXRβ and RXRγ
25. Limited specificity and large overlap of the functions of the mouse RARγ1 and RARγ2 isoforms
26. RXRγ null mice are apparently normal and compound RXRα +/-/RXRβ-/-/RXRγ -/- mutant mice are viable
27. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RARβ2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts
28. Targeted disruption of retinoic acid receptor alpha (RARα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism
29. The targeted disruption of both alleles of RARβ2 in F9 cells results in the loss of retinoic acid-associated growth arrest
30. RAR-β4, a retinoic acid receptor isoform, is generated from RAR-β2 by alternative splicing and usage of a CUG initiator codon
31. Multiple isoforms of the mouse retinoic acid receptor α are generated by alternative splicing and differential induction by retinoic acid
32. Differentially expressed isoforms of the mouse retinoic acid receptor β are generated by usage of two promoters and alternative splicing
33. Murine isoforms of the mouse retinoic acid receptor γ with specific patterns of expression
34. Identification of a novel isoform of the retinoic acid receptor γ expressed in mouse embryo
35. The mouse X receptor-γ gene: Evidence for functional isoforms
36. Ligand specificities of recombinant retinoic acid receptors RAR-α and RAR-β
37. 9-Cis-retinoic acid is a high affinity ligand for the retinoid X receptor
38. 9-Cis-retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha
39. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling
40. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
41. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor
42. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers
43. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro
44. SMRT isoforms mediate repression and antirepression of nuclear receptor heterodimers
45. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
46. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
47. Lineage-specific signaling in melanocytes
48. p27(Kip1): A key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line
49. Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism
50. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells
51. Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells
52. Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines
53. Effect of retinoids on AOM-induced colon cancer in rats: Modulation of cell proliferation, apoptosis and aberrant crypt foci
54. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl) retinamide (4-HPR) following surgical removal of first palpable tumor
55. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity
56. Treatment of prostate cancer in the rat with the synthetic retinoid fenretimide
57. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
58. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors and apoptosis-related genes in human prostate carcinoma cells
59. Mediation of N-(4-hydroxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms
60. Retinoid receptor-dependent and-independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells
61. Suppression of apoptosis by all-trans-retinoic acid. Dual intervention in the c-jun N-terminal kinase-AP-1 pathway
62. High dietary retinoic acid prevents malignant conversion of skin papillomas induced by a two stage carcinogenesis protocol in female SENCAR mice
63. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest
64. Diversity in function and regulation of MAP kinase pathways
65. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors
66. Differential expression of nuclear retinoic acid receptors in normal, premalignant, and malignant head and neck tissues
67. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression
68. 13-Cis-retinoic acid in the treatment of oral leukoplakia
69. Comparison of low-dose isotretinoin with β-carotene to prevent oral carcinogenesis
70. Clinical models of chemoprevention for the esophagus
71. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial
72. Prevention of skin cancer in xeroderma pigmentosum with oral isotretinoin
73. Long-term therapy with low dose isotretinoin for prevention of basal cell carcinoma: A multi-center clinical trial: Isotretinoin-Basal Carcinoma Study Group
74. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: A randomized double-blind controlled trial
75. A clinical trial of β-carotene to prevent basal cell and squamous cell carcinoma of the skin
76. Prevention of cervical intraepithelial neoplasia and cancer
77. Chemoprevention of breast cancer
78. N-(4-hydroxyphenyl) retinamide: A new retinoid for the prevention of breast cancer in the rat
79. Cancer chemoprevention: Progress and promise
80. Beyond tamoxifen: The retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma
81. Evidence for a 15:17 translocation in every patient with acute promyelocytic leukemia
82. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element
83. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion
84. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
85. The effects of 13-cis retinoic acid and interferon-α in chronic myelogenous leukemia cells in vivo in patients
86. Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon α, and granulocyte colony-stimulating factor
87. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cell in vitro
88. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells
89. Retinoids in neuroblastoma therapy: Distinct biological properties of 9-cis- and all-trans-retinoic acid
90. Interferon-γ and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action
91. Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-1 and IGFBP-4 in SK-N-SH human neuroblastoma cells
92. Effects of retinoid on xenotransplanted human mammary carcinoma cells in athymic mice
93. Expression and regulation of retinoic acid receptors in human breast cancer cells
94. Estradiol induction of retinoic acid receptors in human breast cancer cells
95. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function
96. Retinoic acid receptor α expression correlates with retinoic acid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status
97. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
98. Clinical significance of erbB-2 (HER-2/neu) protein
99. Expression of c-erbB-4/HER4 is regulated in T47D breast carcinoma cells by retinoids and vitamin D3
100. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression
101. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
102. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia: 1. Clinical results
103. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
104. Successful treatment of relapse of acute promyelocytic leukemia with a synthetic retinoid, Am80
105. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy and As203: An experience of 120 patients at a single institution
106. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid resistance in patients with acute promyelocytic leukemia
107. 9-Cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia
108. Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells
109. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR mutation
110. Use of retinoic acid in the treatment of peripheral T cell lymphoma: A pilot study
111. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid
112. A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: A gynecologic oncology group study
113. Oxygenation of cervical cancer during radiotherapy and radiotherapy + cis-retinoic acid/interferon